Form 8.3 - Udg Healthcare Plc

 
TIDMUDG 
 

U.K. DISCLOSURE, Aug. 16, 2021 (GLOBE NEWSWIRE) --

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

   1.    KEY INFORMATION 
 
  Name of person dealing (Note 1)                           Glazer Capital, 
                                                            LLC 
--------------------------------------------------------  -------------------- 
  Company dealt in                                          UDG Healthcare plc 
--------------------------------------------------------  -------------------- 
  Class of relevant security to which the dealings being    EUR0.05 ordinary 
   disclosed relate (Note 2)                                shares 
--------------------------------------------------------  -------------------- 
  Date of dealing                                           August 13, 2021 
--------------------------------------------------------  -------------------- 
 
   2.    INTERESTS AND SHORT POSITIONS 
   (a)    Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) 
 
                                                 Long              Short 
-----------------------------------  ----------------------  ------------- 
                                       Number         (%)      Number  (%) 
-----------------------------------  ---------------  -----  --------  --- 
  (1) Relevant securities                            0 (0%)         0 (0%) 
-----------------------------------  ----------------------  ------------- 
  (2) Derivatives (other than 
   options)                              13,304,375 (5.28%)         0 (0%) 
-----------------------------------  ----------------------  ------------- 
  (3) Options and agreements to 
   purchase/sell                                     0 (0%)         0 (0%) 
-----------------------------------  ----------------------  ------------- 
  Total                                  13,304,375 (5.28%)         0 (0%) 
-----------------------------------  ----------------------  ------------- 
 
   (b)    Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) 
 
  Class of relevant security:                           Long           Short 
----------------------------------------------  ---------------  --------------- 
                                                  Number    (%)    Number    (%) 
----------------------------------------------  --------    ---  --------    --- 
  (1) Relevant securities 
----------------------------------------------  ---------------  --------------- 
 
   (2) Derivatives (other than options) 
----------------------------------------------  ---------------  --------------- 
 
   (3) Options and agreements to purchase/sell 
----------------------------------------------  ---------------  --------------- 
  Total 
----------------------------------------------  ---------------  --------------- 
 

Ap20

   1.    DEALINGS (Note 4) 
   (a)    Purchases and sales 
 
 
   Purchase/sale     Number of relevant securities     Price per unit (Note 5) 
----------------  --------------------------------  -------------------------- 
 
 
   (b)    Derivatives transactions (other than options transactions) 
 
  Product name,    Nature of transaction    Number of relevant securities    Price per unit 
   e.g. CFD         (Note 6)                 (Note 7)                         (Note 5) 
---------------  -----------------------  -------------------------------  ---------------- 
  CFD              Decreased Long           1,508,838                        10.79 GBP 
---------------  -----------------------  -------------------------------  ---------------- 
 
 
 
 
 
   (c)    Options transactions in respect of existing relevant securities 
   (i)    Writing, selling, purchasing or varying 
 
  Product name,        Writing,       Number of securities to which the option relates (Note    Exercise    Type,        Expiry    Option money 
   e.g. call option    selling,        7)                                                       price       e.g.         date      paid/received 
                       purchasing,                                                                          American,              per unit 
                       varying                                                                              European               (Note 5) 
                       etc.                                                                                 etc. 
-------------------  -------------  --------------------------------------------------------  ----------  -----------  --------  --------------- 
 
 
   (ii)    Exercising 
 
  Product name,        Number of securities    Exercise price per unit (Note 
   e.g. call option                            5) 
-------------------  ----------------------  --------------------------------- 
 
 
   (d)    Other dealings (including transactions in respect of new securities) (Note 4) 
 
  Nature of transaction    Details    Price per unit 
   (Note 8)                            (if applicable) (Note 5) 
-----------------------  ---------  --------------------------- 
 
 

Ap21

   2.    OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

 
  Full details of any agreement, arrangement or understanding 
   between the person disclosing and any other person 
   relating to the voting rights of any relevant securities 
   under any option referred to on this form or relating 
   to the voting rights or future acquisition or disposal 
   of any relevant securities to which any derivative 
   referred to on this form is referenced. If none, this 
   should be stated. 
------------------------------------------------------------- 
 
       None 
------------------------------------------------------------- 
 

Is a Supplemental Form 8 attached? (Note 9) YES/NO

 
  Date of disclosure                                         August 16, 2021 
---------------------------------------------------------  ----------------- 
  Contact name                                                Megan Boylan 
---------------------------------------------------------  ----------------- 
  Telephone number                                            [phone] 
---------------------------------------------------------  ----------------- 
  If a connected EFM, name of offeree/offeror with which 
   connected 
---------------------------------------------------------  ----------------- 
  If a connected EFM, state nature of connection (Note 
   10) 
---------------------------------------------------------  ----------------- 
 
 
 

(END) Dow Jones Newswires

August 16, 2021 10:30 ET (14:30 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.